Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) believes that in
the future, up to 80 percent of its total revenue could stem from licensing
deals for its patented DehydraTECH™ delivery technology. An article discussing
the company reads: “The company’s patented DehydraTECH™ is key to LXRP’s
valuation. The technology is being tested in human clinical studies for the
delivery of cannabinoids through ingestible means. Results thus far have shown
increased absorption rates with reduced time to enter the bloodstream and
reported improvements in the taste and smell of edible products. … Lab tests on
mice have shown a 50 percent improvement in active ingredients, such as
nicotine, being absorbed into the bloodstream. They demonstrated even higher
percentage levels absorbed into the brain. Bunka said that these results could
potentially have an important impact on future treatment of cancer and brain
tumors.”
To view the full article, visit http://ibn.fm/f47c3
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. develops and out-licenses its
disruptive delivery technology that promotes healthier ingestion methods, lower
overall dosing and higher effectiveness of lipophilic active molecules. Lexaria
has multiple patents pending in over 40 countries around the world and has
patents granted in the U.S. and Australia for utilization of its DehydraTECH™
delivery technology. Lexaria’s technology provides increases in intestinal
absorption rates; more rapid delivery to the bloodstream; and important
taste-masking benefits for orally administered bioactive molecules, including
cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),
nicotine and other molecules. For more information, visit the company’s website
at www.LexariaBioscience.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment